Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-20 7:44 pm Sale | 13G | MOBIQUITY TECHNOLOGIES INC MOBQ | Lind Global Fund II LP | 8,000 0.000% | -114,695 (-93.48%) | View |
| 2024-11-14 7:34 pm Purchase | 13G | Blue Star Foods Corp. BSFC | Lind Global Fund II LP | 103,993 4.000% | 103,993 (New Position) | View |
| 2024-11-14 7:33 pm Purchase | 13G | ABVC BIOPHARMA INC ABVC | Lind Global Fund II LP | 1,150,000 9.900% | 380,000 (+49.35%) | View |
| 2024-11-14 7:32 pm Purchase | 13G | SEELOS THERAPEUTICS INC PA SEEL | Lind Global Fund II LP | 44,500 9.900% | 44,500 (New Position) | View |
| 2024-11-14 7:31 pm Sale | 13G | SIDUS SPACE INC SIDU | Lind Global Fund II LP | 0 0.000% | -222,200 (Position Closed) | View |
| 2024-11-14 7:30 pm Sale | 13G | VERSUS SYS INC WT EXP VSSYW | Lind Global Fund II LP | 273,692 9.700% | -1,308 (-0.48%) | View |
| 2024-11-14 7:29 pm Sale | 13G | ORAGENICS INC PAR $0.001 N OGEN | Lind Global Fund II LP | 0 0.000% | -265,000 (Position Closed) | View |
| 2024-11-14 7:29 pm Unchanged | 13G | TOUGHBUILT INDS INC PAR $. TBLT | Lind Global Fund II LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-14 7:28 pm Purchase | 13G | Siyata Mobile Inc. SYTA | Lind Global Fund II LP | 627 0.000% | 627 (New Position) | View |
| 2024-11-14 7:28 pm Purchase | 13G | SENESTECH INC PAR $0.0 SNES | Lind Global Fund II LP | 92,500 9.900% | 92,500 (New Position) | View |
| 2024-11-14 7:27 pm Purchase | 13G | NLS Pharmaceutics Ltd. NLSP | Lind Global Fund II LP | 103,530 8.100% | 103,530 (New Position) | View |
| 2024-11-14 7:25 pm Purchase | 13G | SINTX TECHNOLOGIES INC PAR SINT | Lind Global Fund II LP | 71,500 5.100% | 71,500 (New Position) | View |
| 2024-11-14 7:25 pm Purchase | 13G | NETCAPITAL INC NCPL | Lind Global Fund II LP | 119,000 9.900% | 119,000 (New Position) | View |
| 2024-11-14 7:24 pm Purchase | 13G | EDIBLE GARDEN AG INC PAR $ EDBL | Lind Global Fund II LP | 35,750 0.200% | 35,750 (New Position) | View |
| 2024-11-14 7:23 pm Purchase | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Lind Global Fund II LP | 62,500 1.200% | 62,500 (New Position) | View |
| 2024-11-14 7:22 pm Purchase | 13G | PAXMEDICA INC PXMD | Lind Global Fund II LP | 1,008,599 8.800% | 756,829 (+300.60%) | View |
| 2024-11-14 7:21 pm Sale | 13G | CYCLACEL PHARMACEUTICALS INC C CYCC | Lind Global Fund II LP | 0 0.000% | -102,250 (Position Closed) | View |
| 2024-11-14 7:21 pm Purchase | 13G | CINGULATE INC PAR $0.0001 CING | Lind Global Fund II LP | 98,918 3.100% | 98,918 (New Position) | View |
| 2024-11-14 7:20 pm Sale | 13G | BIOLASE INC PAR $.001 BIOLQ | Lind Global Fund II LP | 0 0.000% | -1,190,000 (Position Closed) | View |
| 2024-11-14 7:19 pm Unchanged | 13G | BONE BIOLOGICS CORP COM DE BBLG | Lind Global Fund II LP | 34,180 1.900% | 0 (Unchanged) | View |